Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies.
- DOI
- 10.1136/rmdopen-2024-005250
- Published
- 2025-06-03
- Container
- RMD Open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2024-005250,
title = {Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies.},
author = {Gladman D and Tillett W and Gruben D and Coates LC and Hahne S and Volkov M.},
year = {2025},
journal = {RMD Open},
doi = {10.1136/rmdopen-2024-005250},
url = {https://doi.org/10.1136/rmdopen-2024-005250}
}RIS
TY - JOUR TI - Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies. AU - Gladman D AU - Tillett W AU - Gruben D AU - Coates LC AU - Hahne S AU - Volkov M. PY - 2025 JO - RMD Open DO - 10.1136/rmdopen-2024-005250 UR - https://doi.org/10.1136/rmdopen-2024-005250 ER -
APA
D, G., W, T., D, G., LC, C., S, H., & M., V. (2025). Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies.. RMD Open. https://doi.org/10.1136/rmdopen-2024-005250
Source records
- europe-pmc · retrieved 2026-09-27T00:19:15.714Z
- doaj · retrieved 2026-09-27T00:19:15.720Z